Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
World Journal of Urology|October 28, 2025
Outcomes of aquablation: pooled analysis from the WATER, WATER II, OPEN WATER, FRANCAIS WATER, and JAPAN PMS studiesMario Henrique Bitar Siqueira, Mohamad Baker Berjaoui, Naeem Bhojani, et al.
Prostate Cancer and Prostatic Diseases|May 27, 2023
Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysisMassimiliano Creta, Celeste Manfredi, Davide Arcaniolo, et al.
Urology|August 13, 2023
Aquablation in Patients on Antithrombotics: Assessment of Safety, Postoperative Bleeding Rates and Clinical OutcomesIman Sadri, Anindyo Chakraborty, David-Dan Nguyen, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm3 and 80-150-cm3 prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm3 and 80-150-cm3 ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
BJU International|October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
The Journal of Urology|July 24, 2012
A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuriaPaul O'Sullivan, Katrina Sharples, Mark Dalphin, et al.
Urology|April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc ProstatesAnis Assad, David-Dan Nguyen, Neil Barber, et al.
The Canadian Journal of Urology|February 18, 2020
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trialPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Advances in Therapy|April 28, 2019
Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements SustainedPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Pageof 6